Comments
Loading...

Evelo Biosciences

EVLOOTCEM
Logo brought to you by Benzinga Data
$0.316500
-0.32-99.97%
At close: Sep 18, 2:44 PM EDT
15 minutes delayed
Consensus Rating1
Market Outperform
Highest Price Target1
$41.50
Lowest Price Target1
$2.50
Consensus Price Target1
$18.00

Evelo Biosciences (OTC:EVLO) Stock, Analyst Ratings, Price Targets, Forecasts

Evelo Biosciences Inc has a consensus price target of $18 based on the ratings of 4 analysts. The high is $41.5 issued by JMP Securities on November 2, 2021. The low is $2.5 issued by Chardan Capital on November 16, 2022. The 3 most-recent analyst ratings were released by Morgan Stanley, Morgan Stanley, and Chardan Capital on July 26, 2023, February 15, 2023, and November 16, 2022, respectively. With an average price target of $4.83 between Morgan Stanley, Morgan Stanley, and Chardan Capital, there's an implied 4833233.33% upside for Evelo Biosciences Inc from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
2.6
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Morgan Stanley
Chardan Capital
JMP Securities

1calculated from analyst ratings

Analyst Ratings for Evelo Biosciences

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Evelo Biosciences (EVLO) stock?

A

The latest price target for Evelo Biosciences (OTCEM:EVLO) was reported by TD Cowen on October 18, 2023. The analyst firm set a price target for $0.00 expecting EVLO to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Evelo Biosciences (EVLO)?

A

The latest analyst rating for Evelo Biosciences (OTCEM:EVLO) was provided by TD Cowen, and Evelo Biosciences downgraded their market perform rating.

Q

When was the last upgrade for Evelo Biosciences (EVLO)?

A

The last upgrade for Evelo Biosciences Inc happened on November 1, 2021 when Chardan Capital raised their price target to $12. Chardan Capital previously had a neutral for Evelo Biosciences Inc.

Q

When was the last downgrade for Evelo Biosciences (EVLO)?

A

The last downgrade for Evelo Biosciences Inc happened on October 18, 2023 when TD Cowen changed their price target from N/A to N/A for Evelo Biosciences Inc.

Q

When is the next analyst rating going to be posted or updated for Evelo Biosciences (EVLO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evelo Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evelo Biosciences was filed on October 18, 2023 so you should expect the next rating to be made available sometime around October 18, 2024.

Q

Is the Analyst Rating Evelo Biosciences (EVLO) correct?

A

While ratings are subjective and will change, the latest Evelo Biosciences (EVLO) rating was a downgraded with a price target of $0.00 to $0.00. The current price Evelo Biosciences (EVLO) is trading at is $0.00, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.